Life Science Instruments & Reagents Market Size, Share, Growth, and Industry Analysis, By Type (Instruments and Reagents), By Application (Commercial, Clinical, Academic, and Others), Regional Insights and Forecast From 2025 To 2033

Last Updated: 25 June 2025
SKU ID: 19882611

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET OVERVIEW

The global life science instruments & reagents market size was valued at USD 83.83 billion in 2024 and is projected to touch USD 142.83 billion by 2033, at a CAGR of 6.1% during the forecast period from 2025 To 2033.

Life sciences reagents are chemicals or mixtures that are employed in chemical reactions to track and detect changes. To ascertain a disease's underlying aetiology, medical researchers examine this data. Chemical reactions employ analytical and life science reagents to quantify, find, or study other compounds.  Pharmaceutical, biotechnology, life science, and healthcare sectors all depend on life science reagents. Due to the rise in the use of life science reagents in in vitro diagnostics for the diagnosis of numerous chronic and infectious diseases, the global life science instruments & reagents market is anticipated to experience rapid expansion during the forecast period. Life science instruments & reagents are also used to design treatments, forecast how diseases will develop, and assess how well they are working.

COVID-19 IMPACT

Supply and Lockdown Limitations to Impede Market Advancement

The need for life science instruments & reagents is increasing due to the COVID-19 pandemic, which will drive the market's expansion. A certain infectious disease called COVID-19 has been spreading uncontrollably around the world. The growing number of COVID-19 instances is driving up the demand for tests and various sorts of research that need reagents, which is driving the market under study towards expansion. Furthermore, the market under consideration is anticipated to rise over the course of the forecast period due to the widespread usage of different agents in vaccine research and development.

LATEST TRENDS 

Increasing Geriatric Population to Stimulate Market Development

The lifespan of the world's elderly population is increasing as a result of developments in the health care and life sciences sectors, improvements in public health policies, and a decline in infectious diseases that can be fatal in developed nations. Globally, the elderly population is expanding more quickly than the youth. The elderly population and those with chronic illnesses including diabetes, respiratory conditions, and cancer frequently need medical tests like blood tests and urine tests as part of preventive health care. During the forecast period, this is anticipated to boost the life science instruments & reagents market growth.

Life Science Instruments and Reagents Market, Share, 2033

ask for customizationRequest a Free sample to learn more about this report

LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET SEGMENTATION

By Type

Based on type; the market is divided into Instruments and Reagents.

By Application

Based on the application; the market is divided into Commercial, Clinical, Academic, and Others.

DRIVING FACTORS

Technological Advancements to Aid Market Expansion

The increased frequency of infectious disorders and technical developments in the life sciences and biotechnology industries are some of the reasons boosting market expansion. Viruses, parasites, and other pathogenic microbes are to blame for the high occurrence of infectious disorders. These illnesses can be passed from one person to another either directly or indirectly. If precautions are not taken, they are easily spread and highly transmittable. In many impoverished and underdeveloped nations, these diseases can be fatal due to a lack of healthcare infrastructure and facilities.

R&D Activities to Foster Industry Progress

The expansion of the global life science reagent market is anticipated to be driven by an increase in product launches for reagents to support various sorts of diagnostic testing and research purposes. For instance, to increase the Nadia Instrument offering, single cell technologies company Dolomite Bio introduced a new scRNA-Seq reagent kit in March 2019.

RESTRAINING FACTORS

Harmful Effects to Hinder Market Advancement

The high cost of reagents and the strict regulatory environment serve as roadblocks to market expansion.

LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET REGIONAL INSIGHTS

Increasing patient Pool to Foster Market Advancement in North America

North America holds the largest part of the global life science instruments & reagents market share. This is due to the region's abundance of biotechnology and pharmaceutical firms. Due to the reagents' widespread use in all types of research—diagnostic, therapeutic, drug development, and other—the U.S. is the nation that is most impacted globally. Due to the fact that the patient population in North America is growing relative to other nations, the demand for the same will be substantially larger.

Due to factors like early adoption of cutting-edge technology, rising funding for medical research, rising healthcare spending, and a supportive regulatory framework, Asia Pacific is expected to develop at a double-digit CAGR during the projection period.

KEY INDUSTRY PLAYERS

Innovative Creations by Manufacturers to Increase Market Growth

The life science instruments & reagents market is competitive and fragmented, with a number of significant companies. A select number of the big firms presently control the majority of the market in terms of market share.

List of Top Life Science Instruments And Reagents Companies

  • Thermo Fisher Scientific (U.S.)
  • Merck (U.S.)
  • Danaher (U.S.)
  • GE Healthcare (U.S.)
  • BD (U.S.)
  • Roche (Switzerland)
  • Agilent Technologies (U.S.)
  • BioMerieux (France)
  • Bio-Rad Laboratories (U.S.)
  • PerkinEkmer (U.S.)
  • Waters (U.S.)
  • Bruker (U.S.)
  • Shimadzu (Japan)
  • Abcam (U.K.)

REPORT COVERAGE

This assessment conveys a report with getting evaluations that consider the portrayal freed from the affiliations that exist in the market influencing the focusing in on a time span. The report offers a sensible procedure for driving associations with their strong appearance structures, market risk, and late new developments. With the help of point-by-point research done, it offers a full-scale assessment by looking at the parts like division, expected open segments, present day refreshes, plans, improvement, size, shares, drivers, blocks, and others. This assessment can be changed supporting through the focal people and possible assessment of market parts changes.

Life Science Instruments & Reagents Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 83.83 Billion in 2024

Market Size Value By

US$ 142.83 Billion by 2033

Growth Rate

CAGR of 6.1% from 2024 to 2033

Forecast Period

2025-2033

Base Year

2024

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • Instruments
  • Reagents

By Application

  • Commercial
  • Clinical
  • Academic
  • Others

FAQs